Full Program
RE(ACT) Congress & IRDiRC Conference 2025
*This program is subject to change without notice at any time*
Times are in CET.
WEDNESDAY, MARCH 5h
Opening speech, 8h45 to 9
Plenary Talk on AI, 9 to 10
Session A, 10 to 13, « Diagnosing rare diseases: from NBS to machine learning »
Chairs: Helen Malherbe (ZA) and Alexander Hoischen (NL)
Lunch break and Poster Sessions A & B 13 to 14h30
Session B, 14h30 to 17h30 « Empowering data »
Chairs: Lindsey Murray (US) and Ronald Cornet (NL)
- Nicole Vasilevsky, US « Accelerating Rare Disease Treatment: The Role of Data Sharing in the RDCA-DAP »
- Sabine Österle, CH « The Swiss Personalized Health Network- from clinical routine data to FAIR research data »
- Thomas Hellebrand, BE
- Marieke Bak, NL
- Trudy Nyakambangwe, ZI – TBC
THURSDAY, MARCH 6th
Plenary Talk on Regulatory Science, 9 to 10
Session C, 10 to 13, « ATMPs: challenges and opportunities of today »
Chairs: PJ Brooks (US) and Eleni Papanikolou (DE)
- Axel Schambach, DE – TBC
- Nick Sireau, UK « Challenges and opportunities for mRNA therapy for rare genetic diseases »
- Tiziana Cremona, CH
- Johan Flygare, SE
- Christian Seitz, DE – TBC
- Selim Corbacioglu, DE – TBC
- Rupert Handgretinger, DE – TBC
Lunch break and Poster Sessions C & D 13 to 14h30
Session D, 14h30 to 17h30, « Impacts of rare diseases on patients, families, and society »
Chairs: Virginie Hivert (FR) and Gareth Baynam (AU)
- Sue Baker, AU « Impact of a Cross-Sector (Inter-Agency) Care Coordination Program for Children and Families Living with Rare and Undiagnosed Diseases (RUDs) »
- Gina Cioffi, US « Can Highlighting the Societal Value of Rare Disease Treatments Lead to Improved Health? »
- Kirsten Johnson, UK « Mental health and rare conditions: an integrated approach to care and research »
- Sofie Skoubo, DK « School absence legislation governing in Norway, Sweden, and Denmark for children with chronic illness in compulsory education—A comparative study »
Social event, 18h30 To be confirmed
FRIDAY, MARCH 7th
Session E, 9 to 12, « Funding models »
Chairs: Adam Hartman (US) and Magda Chlebus (BE)
Lunch break and Poster Sessions E & F 12 to 13h30
Session F, 13h30 to 16h30, « Drug repurposing in rare diseases »
Chairs: Samantha Parker (FR) and Donald Lo (NL)
- Philip Gribbon, DE
- Catriona Crombie, UK
- Lindsay Randal, UK
- Paolo Bettica, IT « Challenges and opportunities in developing multiple orphan indications for the same medicine »
Best posters prize & Closing Ceremony
Program updated November 25, 2024